| | Complex Visual Hallucinations in the Visually Impaired: The Charles Bonnet SyndromeAbstract Visually impaired patients may experience complex visual hallucinations, a condition known as the Charles Bonnet Syndrome. Patients usually possess insight into the unreality of their visual experiences, which are commonly pleasant but may sometimes cause distress. The hallucinations consist of well-defined, organized, and clear images over which the subject has little control. It is believed that they represent release phenomena due to de-afferentation of the visual association areas of the cerebral cortex, leading to a form of phantom vision. Cognitive defects, social isolation, and sensory deprivation have also been implicated in the etiology of this condition. This condition, which is most common in the elderly, frequently goes unrecognized in clinical practice, due to both lack of awareness among doctors and patients' reluctance to admit to hallucinatory experiences, for fear of being labeled mentally unstable. Furthermore, patients who comprehend the unreality of their hallucinations may be distressed by the real fear of imminent insanity. Sensitive and sympathetic history taking is essential to ascertain the existence of hallucinations. Reassurance and explanation that the visions are benign and do not signify mental illness have a powerful therapeutic effect. Hallucinatory activity may terminate spontaneously, on improving visual function or on addressing social isolation. There is no universally effective drug treatment but anticonvulsants may play a limited role in aborting the hallucinations. Physician awareness and empathy are the cornerstones of management.
Visual hallucinations occur in a variety of settings: psychiatric disease, drug ingestion, sleep–wake transitional states, metabolic and endocrine disorders, epilepsy, cerebral ischemia, and other forms of neurological disease.8, 94, 107, 128
Deterioration of vision secondary to a wide spectrum of ophthalmic and neurological disease is a common accompaniment of advancing age. It is however, perhaps not widely appreciated that a considerable proportion of visually impaired individuals experience formed visual hallucinations, which are sometimes distressing. This condition is known as the Charles Bonnet Syndrome (CBS).
I. History  The eponym was coined by de Morsier,33, 34 recognizing the renowned Genoese naturalist, philosopher, and biologist Charles Bonnet (1720–1793), who in 1769 described the hallucinatory experiences of his grandfather Charles Lullin,18 in probably the first scientific documentation of a hallucinatory experience.32 Lullin, an intelligent and articulate 89-year-old magistrate, described subjective perception of silent visions of men, women, birds, carriages, and buildings, varying in size, shape, and place, occurring in association with visual deterioration after bilateral cataract surgery,46 while maintaining intact cognition and fully realizing that his visions were “fictions” of his brain.31, 42 Ironically Bonnet, deaf from the age of 7, himself suffered deterioration of vision early in life, and he manifested symptoms typical of the syndrome which now bears his name.32, 90
II. Definitions  Perception is the intuitive recognition of stimuli presented through the sense organs, while imagery is an experience within the mind, usually without the sense of reality that characterizes perception. Imagery so intense as to accord a photographic quality is referred to as eidetic. Eidetic imagery may persist, especially when looking at poorly structured backgrounds. This phenomenon, characterized by the simultaneous existence of real and unreal images (the subject being aware of the unreality of the latter), is called pareidolia. This is distinct from palinopsia, in which visual perseveration results in persistence of a prior image when a new direction of gaze is assumed. An illusion is a misrepresentation of an external stimulus, exemplified by the mistaking of a rope for a snake.19, 38, 51 A hallucination is a sensory experience, possessing the compelling sense of reality of a true perception, but occurring without external stimulation of the relevant sensory organ.5, 19, 80 A similar phenomenon, where the subject is aware of the unreality of the sensory experience may be termed a pseudohallucination,80, 83, 131, 134, 137 though the utility of this term has been challenged.51, 119 Visual hallucinations may be elementary or complex. Elementary hallucinations (also called phosphenes, photopsiae, or unformed visual hallucinations) consist of colored or colorless bright lights, such as points, flashes, stars, and sparks. In contrast, complex visual hallucinations consist of formed images of objects or persons, sometimes related to past experiences of the subject.38, 83, 94 De Morsier32 defined CBS as the occurrence of visual hallucinations in elderly people with intact cerebral function. Noting that ocular pathology was often present in these elderly subjects, he nevertheless considered visual impairment not to be causative and therefore not obligatory for diagnosis.32, 33 CBS has subsequently been described as the occurrence of recurrent or persistent complex visual hallucinations often of a pleasant nature,31 which may be considered pseudohallucinations,11, 24 in individuals with preserved insight53 and intellectual function31 without altered consciousness, cognitive or psychiatric disturbances, sleep disorders, or focal neurological lesions10, 12, 24, 30, 122, 128 and often associated with ophthalmic pathology.31, 64, 132
III. Epidemiology  CBS occurs predominantly in elderly, visually impaired people.116, 144 A. Prevalence Historically, hallucinatory experiences have been deemed to signify mental instability;8 patients are therefore often reluctant to admit to their hallucinatory experiences. The prevalence of CBS is thus likely to be underestimated.12, 83, 116, 132 The prevalence of complex visual hallucinations in patients with visual impairment has been estimated at between 11% and 15%.21, 44, 70, 82, 86, 109, 145, 147 A similar incidence of complex visual hallucinations has been reported in patients subjected to sensory deprivation by means of ocular masking prior to cataract surgery.92 In psychogeriatric patients over the age of 65 the prevalence of CBS has been estimated at between 1.84% and 3.5%.107, 108 Elementary visual phenomena however, occur more frequently; their incidence has been estimated at between 41% and 59% in visually impaired patients.21, 52, 89, 124, 151 B. Age distribution CBS is more common in the elderly.24, 32, 71, 116, 121, 128 Major case series reveal mean ages of incidence of 83.8,107 78.4,145 75.7,116 and 74.970 years. Other investigators report similar figures.53, 77, 146, 148, 150 However, the condition has also been reported in children sustaining rapid visual loss.130, 155 It has been suggested that the predilection for the elderly merely reflects the increased incidence of sudden profound visual loss in that age group.130 C. Sex distribution Different case series yield varying figures on the relative prevalence of CBS in men and women. De Morsier32 originally reported a male preponderance. Other studies suggest a clear preponderance of women;53, 71, 107, 108, 128, 145, 148 yet others recognize no sex bias.42, 49, 116, 146 D. Under-recognition CBS frequently goes unrecognized in clinical practice.21, 89, 147 Patients who admit to experiencing hallucinations are often labeled demented or psychotic,60 while potentially treatable causative factors are ignored.122 Many authors draw attention to the unfamiliarity of medical personnel with CBS and the tendency to misdiagnose mental illness.21, 59, 89, 107 In one series of 60 CBS patients, only 16 had consulted a doctor about their hallucinations; of these 16, one was diagnosed correctly.147 There is also the account of an elderly woman with CBS who would have been confined to a mental institution, had it not been for the intervention of a knowledgeable social worker.60 Arguably one of the most illustrative examples is a study of 50 patients with probable Alzheimer's disease, in which hallucinatory activity was exclusively confined to those who were visually impaired.22 It has been subsequently pointed out that, despite recognizing the association between hallucinations and impaired visual acuity, and that optimizing visual acuity by optical means often reduced the occurrence of hallucinatory experiences, the possibility of CBS as part of the differential diagnosis tends not to be considered.140 Awareness of CBS among medical personnel is therefore essential to avoid the risk of inappropriate therapy for non-existent psychiatric disease.104, 107
IV. Clinical Features  One of the earliest descriptions of the clinical features of CBS is that of Ernest Naville,103 who described his own visual hallucinations as intriguing, non-deceptive, non-distressing, exclusively visual experiences (without auditory accompaniment), occurring during clear consciousness and normal perception. He was unable to consciously control the appearance and disappearance of his visions; they vanished on closing his eyes. A. Content Hallucinatory content has been variously described. The most common image is that of a person.116 Disembodied distorted faces; small costumed figures and branching structures;125 vivid images of animals and figures;94 subtle geometric forms; well-defined complex figures; faces; Lilliputian (miniaturized),21, 31, 32, 83 normal-sized,32, 104 and “larger than life” images;32, 71 in black and white—or more commonly—in color,31, 49, 83, 104, 116, 128, 147, 156 of varying degrees of complexity128 have also been described. These hallucinations are always localized in external space,31, 42, 49, 132 and the contents are well organised, defined and brilliantly clear.104, 109, 125, 128, 156 In the context of coexistent visual impairment, the clarity of the visions contrasts sharply with the blurred perception of real objects.11, 31, 49, 132, 156 Patients may perceive visions of themselves, sometimes at earlier stages in their lives, a phenomenon referred to as heautoscopia46, 82 or autoscopia.80, 83 Déjà vu experiences are rare; subjects rarely recognize the figures as living or deceased acquaintances.116 It is unclear whether the images represent playback of previous visual memories.128 The typical CBS hallucination has been variously described as a sudden sharply focused, immobile image, most often the face or figure of a person, which occurs when the patient is alert, with eyes open and vanishes spontaneously after a period of seconds.129 Alternatively it has been described as a solitary constant solid object in the central visual field, most commonly a flash, but often a complex grid, a disembodied distorted face, a small costumed figure with a hat or a branching structure.125 Atypical CBS hallucinations, classified into atypical sensory-perceptual (ASP) and atypical psychodynamic (APD) varieties, have also been described. ASP hallucinations differ from typical complex visual hallucinations in one or more characteristics such as duration, movement, volition, or participation of another sense (the latter widely considered an exclusion criterion for Charles Bonnet Syndrome), whereas APD hallucinations, similar to dreams, are more complex, mirroring the subject's psychological state, changing in content and frequency with alterations in the person's inner life or daily activities and may be repetitive.105 B. Movement There is no uniformity of opinion regarding the presence or absence of movement of hallucinatory images. Images have been described as static,129 moving en bloc (without internal change)42, 49, 116 or dynamic (with internal movement).31, 65, 128 C. Stereotypy The criteria of Gold and Rabins53 specify that the visual hallucinations in CBS be stereotyped. Recurrent themes21, 82, 100 and minimal variability in individual subjects109 have been noted in many subjects; however, many investigators have reported hallucinatory content varying between patients and even in the same patient at different times.21, 83, 104, 147, 148 It has therefore been recommended that the criterion mandating stereotypy of hallucinatory content should be abandoned.148 However, when images are dynamic (animated), the pattern of internal movement tends to be stereotyped.128 D. Triggering and relieving factors These hallucinations typically occur independently of any triggering factors or exercise of volition in the genesis of the image.104, 129 In some individuals however, they may be triggered by a wide variety of stimuli,42 such as conditions of general sensory reduction,91 fatigue,109 stress,82 low levels of illumination122, 128 or even by bright light.156 Once manifest, images last for periods varying from seconds through minutes to hours12, 21, 49, 83, 94, 96, 104, 109, 116, 122, 128, 152 and subsequently disappear, either spontaneously, or in response to actions such as closing the eyes27, 32, 42, 94, 128, 147, 148 and executing ocular saccades.27, 54, 82, 83, 128 Measures such as looking directly at the images,82 attempting to approach them,122 and conversing with them87 have also been reported to terminate hallucinations. A clinical approach, which investigates the utility of any such strategies, may be warranted. Eye closure may both trigger and terminate hallucinations.31, 53, 148 Hallucinations have been reported to occur when the eyes are closed.141, 147 E. Course After impairment or loss of vision, hallucinations usually appear after a latent period lasting from hours to days.82 They may commence gradually, or more commonly exhibit a sudden onset, often occurring several times a day.21, 49, 83, 94, 104, 116, 128 Hallucinations may then continue to occur over varying periods from days through months to years.31, 82, 116, 122, 128 They tend to fade as sight is finally lost,42, 156 usually disappearing several months after the onset of the disorder, but are prone to reappear under conditions of physical or emotional stress.83 Three patterns of disease—episodic, periodic, and continuous—have been described.32, 116 The episodic variety, in which hallucinations occur over a period of days to months and then permanently resolve, is the least common.13 The periodic pattern of disease is characterized by phases of hallucinatory activity alternating with phases of remission, whereas patients manifesting the continuous pattern experience no hallucination-free intervals. Elementary visual hallucinations may progressively evolve into complex visual hallucinations;31, 87, 116, 152 less frequently complex visual hallucinations regress to simple visual phenomena as they gradually cease to occur.87 F. Hallucinations of other modalities Most authorities maintain that the hallucinatory experiences of CBS are exclusively visual, unaccompanied by noise18, 31, 32, 87 or hallucinations of other senses.11, 109, 132 It has been recommended that such silent visual hallucinations should alert clinicians to the possibility of dysfunction of the visual pathway.151 Auditory hallucinations in association with complex visual hallucinations have, however, been described;74, 108 it has therefore been suggested that the coexistence of hallucinations of other modalities does not preclude a diagnosis of CBS, provided subjects retain insight into the unreality of their experiences.74 G. Patients' reaction to their hallucinations Reports on patients' reaction to the images are variable. Some investigators emphasize that patients find their hallucinations pleasant,3, 12, 31, 53, 116, 128 purportedly due to preserved central nervous function and adaptability.94 Others however, counter that CBS hallucinations are not invariably pleasant experiences.16, 21, 48, 62, 71, 96, 108, 129, 147, 148 Emotional response may be related to the nature of hallucinatory content.31 A quarter of CBS patients manifest anger, anxiety, or mild paranoia in response to the imagery.49, 125 Reactions to these visual experiences vary from indifference, through curiosity and irritation to terror.31, 38, 48, 62, 104, 128 Based on numerous reports describing patient reluctance to share their experiences16, 108, 109, 148, 156 and personal observation, it has been suggested that the positive response to hallucinations documented in the literature may be over-rated.148 Other investigators however, counter that patients with CBS discuss their hallucinations freely and objectively.152 Unlike the images seen in psychiatric states such as schizophrenia and depression, CBS hallucinations infrequently consist of images capable of generating emotional distress.94, 148, 152 Some authors draw a distinction between a predominantly positive reaction to hallucinatory content on the one hand, and anxiety and distress at the existence of hallucinatory activity on the other.104, 116 Though most patients experience no practical problems, continuous visual hallucinations occurring while the subject is in motion can interfere with navigation.104 H. Insight Most investigators agree that patients with CBS retain full insight into the unreality of their hallucinations,31, 82, 89, 94, 109, 132, 143, 147 which may therefore may be considered pseudohallucinations.11 However, insight may not be immediate. On initial appearance of hallucinations, patients may not recognize the unreality of their visions.31, 83, 116 Accurate insight is often achieved after initial deception,31, 49, 143 especially if the perceived images are appropriate to and fit realistically into the surroundings.143 Accordingly, patients may react to their hallucinations, trying to hit them away or grab them.71 The utility of the terms hallucinations and pseudohallucinations in CBS has been challenged on this basis.32 Furthermore, insight is not an all-or-none phenomenon; it may come and go, and even when present, may vary in degree.137 Accordingly, studies suggest that a considerable proportion of CBS patients possess partial or fluctuating insight into their symptomatology.53, 108 I. The mental state Lack of agreement exists regarding the mental state in CBS patients. Many authors emphasize the absence of depression or other demonstrable psychopathology in CBS.31, 70, 71, 109, 127, 128, 146, 148 It has been suggested that subtle confusional states in the elderly may be relevant in the development of CBS.16 Depression has also been observed in CBS patients with considerable frequency.127 Cognitive impairment has been documented in CBS patients;30 cases of CBS have developed dementia on follow-up.53 The prevalence of CBS may be higher in individuals with lower cognitive scores and impaired cognitive status may be a predisposing factor for CBS.70, 71 Subjects lacking insight into the unreality of their hallucinations typically demonstrate significant cognitive impairment compared with those with normal insight. On this basis, it has been suggested that patients with CBS manifest neuropsychological changes characteristic of early dementia, which are however, often overlooked due to lack of sensitivity of screening test measures such as the Mini-Mental State Examination (MMSE), to subtle cognitive decline in the early stages of dementia.114 It is therefore proposed that visual hallucinations may represent an early marker for dementia in the elderly and that visual impairment occurring in the early stages of cognitive decline unmasks these hallucinations.113, 114 This has, however, been contested on the grounds that patients who lack insight do not meet criteria53 for the diagnosis of CBS,143 and on the basis of documented stable cognitive scores on follow up of CBS patients with macular degeneration.69 It has also been argued that the failure of patients to experience distress on account of their hallucinations reflects compromised awareness of the significance of the symptom and provides further evidence that CBS and dementia lie on the same continuum of cognitive decline.115 The term Charles Bonnet Plus has been proposed in the presence of cognitive impairment.10 This has however, been deemed unnecessary, on the admittedly controversial basis that some degree of cognitive impairment is universally present in CBS patients.113 It is interesting that hypoperfusion of the mid-parietal and occipital areas of the brain, a well-recognized pattern in Alzheimer's disease and other dementias, has been documented on single photon emission computed tomography (SPECT) in a patient with CBS.58 It has been argued that cognitive or visual deficits alone are unlikely to cause hallucinations, but together they may contribute to a state of sensory deprivation.30 CBS patients with significant cognitive impairment may well represent a different sub-group to those who present to ophthalmologists primarily on account of poor vision, which may account for the diversity of views in this area. J. fear of insanity Hallucinations have historically been deemed to signify psychiatric disease. Numerous reports describe patients' reluctance to admit to their hallucinatory experiences for fear of being considered psychiatrically unstable.1, 11, 15, 21, 42, 52, 54, 60, 70, 83, 89, 93, 109, 132, 139, 146, 147, 148, 149, 156 Many investigators draw attention to the fear of imminent insanity in the mind of a patient who knows their visions are not real.49, 60, 68, 83, 101, 116, 129, 149 Moreover, care providers, relatives, and friends may think the patient with CBS is mad.54 It is well recognized that many patients experience relief when told that their hallucinatory experiences are normal and do not signify psychiatric disease.70, 146, 147 K. visual function There is no consensus on whether visual pathology is necessary for the development of CBS. Many investigators report a strong association between CBS and impaired vision;2, 15, 31, 42, 52, 53, 65, 70, 82, 83, 89, 94, 107, 109, 116, 128, 146, 148, 156 the most commonly associated ocular pathology is age-related macular degeneration,94 although CBS has been documented in the context of visual impairment secondary to pathology anywhere along the visual pathway, from eye to occipital cortex.37, 41, 82, 85, 96, 117 Such visual hallucinations do not occur in those born blind, but only in the context of acquired visual impairment.110 It has been suggested that CBS is almost invariably associated with impaired vision;122, 128 indeed some authors mandate diminution of visual acuity,64 obligatorily secondary to ocular pathology83 to diagnose CBS. Others116, 148 concur with de Morsier's original opinion32 that visual dysfunction, though common, is not mandatory for diagnosis. Hallucinations may occur more commonly in the context of sudden and unexpected reduction in visual function.70, 83 The degree of diminution of vision may be more relevant to the occurrence of visual hallucinations than the specific underlying ocular pathology.146 CBS occurs more frequently in higher degrees of visual impairment52, 70, 89, 146 and with bilateral as opposed to unilateral ocular pathology.21, 70, 146 In two separate studies, visual acuity of worse than 20/60 and 0.3 (20/66 approximate) in the better eye has been found to be associated with significant risk of developing visual hallucinations.70, 146 Numerous reports82, 91, 96, 116 suggest that improvement of visual function, spontaneously or by interventional means (such as cataract surgery or neurosurgical procedures) results in cessation or improvement of hallucinatory phenomena. Some reports suggest that complex visual hallucinations have a predilection for blind areas of the visual field,82, 87 whereas other investigators recognize no relationship between the location of the hallucinatory images and objectively blind/scotomatous areas of the visual field.152 It has however, been countered that hallucinations are unrelated to the degree of visual impairment.71, 104, 114 This is supported by the observation that hallucinations may paradoxically cease in response to further deterioration of vision.150 L. quality of life in visually impaired patients Loss of vision, with its profound effects on employment, independence, mobility, and self-esteem, can be an overwhelming personal tragedy. The reactions of adults who have recently suffered loss of vision, include psychic stress, depression, suicidal ideation, anxiety, tearfulness, withdrawal, hallucinations, and insomnia,44 persisting as late as 5 years after the onset of visual loss.45 Patients with macular degeneration manifest poor quality of life and emotional distress ratings, comparable with those of individuals with chronic illnesses such as obstructive airways disease and AIDS.157 M. neurological features On the basis of normal visually evoked potentials (VEP) in a patient with CBS due to bilateral cataracts, it has been suggested that the diagnosis can be confirmed by a normal VEP, the geniculo-striate pathways and occipital lobe being normal in this condition.120 It is however, evident in the light of current knowledge that this is not so, and that CBS can occur due to pathology anywhere along the visual pathway.37, 59, 63, 82, 85, 96, 117, 135, 152 N. other risk factors Multiple factors have been implicated as causative for the complex visual hallucinations seen in CBS. Postulated predisposing factors include social isolation,70, 71, 144 shyness,144 and cerebrovascular disease.70 Fatigue and disturbances of vigilance have been implicated as relevant,94, 109, 116, 145, 147 since hallucinations are more likely to occur during states of drowsiness. Other factors, including stress4, 139 and suggestibility,14 have also been proposed as relevant to the genesis of visual hallucinations. The pre-morbid personality structure and the ability to mobilize visual memories in the absence of normal stimuli has also been highlighted as relevant to the occurrence of complex visual hallucinations.82
V. Diagnostic Criteria  There is lack of consensus regarding the diagnostic significance of ocular pathology, neurological disease, and the cognitive state in the context of CBS. Damas Mora et al described CBS as a condition in which “persistent or recurrent visual pseudo-hallucinatory phenomena of a pleasant or neutral nature occur in a clear state of consciousness. Despite vividness, clarity and impelling character, they are recognized as unreal. The condition tends to occur in the elderly with clinically preserved intellectual functions and is often associated with ocular pathology.”31 Subsequently, various investigators have proposed diagnostic criteria for CBS. The criteria of Podoll et al116 are as follows:
1.The predominant symptom is the occurrence of visual hallucinations in elderly individuals in normal mental health.
2.There is no evidence of delirium, dementia, negative impact on intellectual capacity, deteri- oration as in the affective syndromes, paranoid developments, psychosis, intoxication, or neuro- logical disease.
3.Loss of vision as a consequence of ocular disease is found in most cases as a specifying factor but is not obligatory for diagnosis.
Gold and Rabins,53 noting that most investigators did not include patients with other psychopathology under the term Charles Bonnet Syndrome, suggested the diagnostic criteria, which focus on describing clinical phenomenology rather than etiology and course. Notably these criteria neither require nor exclude ocular or cerebral pathology:
1.Visual hallucinations which are a. Formed b. Complex c. Persistent/repetitive d. Stereotyped
◦Insight is fully or partially retained
The criterion requiring stereotypy of visual hallucinations has been contested on the basis of observed variability of hallucinatory experiences in CBS patients.148 It has also been suggested that these criteria be modified to include the presence of both ophthalmic pathology and cognitive defects on formal neuropsychological testing.114
Vi. Associated Conditions  Charles Bonnet hallucinations have been documented in association with a wide spectrum of pathology of the eyes and visual pathway, including age-related macular degeneration,50, 55, 70, 99, 101, 132, 156 cataract,12, 91 choroideremia,156 corneal opacities,31 glaucoma,31 retinal detachment,31, 132 enucleation,38, 88 multiple sclerosis with optic neuritis,25 retinitis pigmentosa,48 occipital infarction with both homonymous hemianopia37, 82 and bilateral loss of vision,135 venous congestion of occipital cortex due to arteriovenous malformation (which improved after trans-arterial embolisation),85 vertebro-basilar insufficiency,63, 117 estrogen intake,41 in association with macular translocation surgery9 and grief reaction.3, 4 CBS has also been reported in association with AIDS with CMV retinitis,62 suprasellar meningioma with visual loss (neurosurgical excision resulted in cure),96 cranial arteritis with presumed cerebral involvement,59 and pituitary tumors compressing the optic nerves and chiasm.152 Charles Bonnet–type hallucinations have also been documented in the absence of ocular or neurological disease,7, 30, 145 in type II diabetes mellitus with normal vision,56 in leprosy,1 in association with HIV infection, where a possible undetectable effect of HIV on the brain was proposed,95 and in the elderly, where they can occur in the absence of apparent cause.16
Vii. The Neuroanatomic Basis of Complex Visual Hallucinations  Foerster,47 studying the effects of faradic stimulation of various areas of the cerebral cortex, noted that stimulation of area 17 (the area striata) and area 18 resulted in subjective perception of elementary visual sensations/flashing lights, whereas that of area 19 (the visual association area) resulted in the subjective perception of complex formed visual sensations including figures, people, and animals. It has subsequently been suggested that complex hallucinations originate from activity in both areas 18 and 19, while elementary sensations signify activity in area 17, the primary visual cortex.117 It has been proposed that CBS hallucinations arise from entoptic sources,76 but this is unlikely since visual hallucinations also occur in retrobulbar pathology. It is, however, interesting that acute termination of visual hallucinations has been documented in patients with macular degeneration treated with laser photocoagulation, implying that laser therapy may possibly silence spontaneously discharging retinal ganglion cells, in some way responsible for visual hallucinations.69 On the basis of the occurrence of visual hallucinations in the context of calcarine infarction, it has been inferred that, since there cannot be activity in infarcted cortex, the origin must lie in the visual association areas.87 Similarly, the ability to recall visual images from memory in individuals with cortical blindness indicates that primary visual (occipital) cortex does not subserve visual memory or imagination.23 Smaller lesions of the occipital cortices are associated with hallucinations, while more extensive lesions, especially if extending anteriorly, result in loss of visual imagery, since the visual association area, located anterior to the striate cortex, is “released” by small posterior lesions and destroyed by larger, more anterior pathology.94, 151 Functional magnetic resonance imaging (fMRI) has demonstrated that while visual hallucinations are actually occurring, the occipital cortex manifests a reduced response to exogenous visual stimulation, suggesting that this reduced responsiveness to peripheral sensory input, may disinhibit endogenous visual memories, which then emerge into consciousness as hallucinations.79 Neuroimaging studies have also shown that visual hallucinations correlate with phasic activity in specialized visual cortex, the location of which is reflected in hallucinatory content, implying functional specialization of the region, and that increased ventral extra-striate activity persists between hallucinations.43, 125 Activation of different cortical areas may therefore produce different images.6, 69, 123 An association between age-related macular degeneration and color hallucinations has been noted. In this context, it is thought that selective damage to cone photoreceptors at the macula (which subserve color vision) creates selective deafferentation of “color” areas of the visual cortex, with resultant localized hyper-excitability and the manifestation of colored hallucinations.125 Studies of cerebral perfusion during actual hallucinatory experiences suggest that the lateral temporal cortex, corpus striatum, and thalamus are the regions most likely to be responsible for the genesis of complex visual hallucinations.2 It is interesting that positron emission tomography (PET) in subjects experiencing musical hallucinations, in the context of acquired deafness, has demonstrated increased activity in auditory association areas rather than primary auditory cortex.57 The tendency of CBS hallucinations to occur during states of drowsiness has led to the suggestion of a role for the ascending reticular activating system in the prevention of hallucinatory activity. This is supported by the observation that hallucinations occur in brain stem lesions, such as peduncular hallucinosis, affecting this system.94 Further investigations, perhaps utilizing imaging techniques such as PET and SPECT, may prove useful in facilitating a deeper understanding of the neuroanatomical and neurobiological correlates of the Charles Bonnet Syndrome.
Viii. Theories of Pathogenesis  Bonnet himself suggested that these hallucinations have their origin in the part of the brain subserving visual function.18 In 1932 Jackson, conceptualizing the nervous system as a hierarchy of three levels, higher (cortical), middle (sub-cortical), and lower (brain-stem), postulated that higher centers exert a controlling influence on sub-cortical centers, loss of which allows the release of activity in disinhibited sub-cortical centers, resulting in hallucinations.138 A. Sensory deprivation—phantom vision Visual hallucinations occurring in the context of visual loss have been conceptualized as phantom visions28 due to de-afferentation16 and compared with the “phantom-limb” syndrome.12, 16, 104, 128 Visual sensory cortex, when deprived of normal afferent input, may exhibit spontaneous independent activity with resultant conscious imagery,12, 21, 109, 127 a hypothesis supported by the observation that such hallucinations can be abolished by normal or excessive visual stimulation.12 Reduction in sensory input to specific areas of the brain may allow memories of previous perceptions to enter consciousness as hallucinations.8 Visual hallucinations in destructive lesions of the central visual system may relate to pathological activation of other neural regions.6, 69, 123 On the basis that some hallucinatory states are associated with impaired cortical inhibition it has been suggested that images that are “screened out” or censored under normal circumstances, could, in the absence of normal inhibitory activity, reach higher centers and impinge onto consciousness.76 It has also been suggested that visual impairment alone may be insufficient to cause complex visual hallucinations, but together with impaired cognition, may contribute to a state of sensory deprivation with resultant visual phenomena.30 Musical pseudohallucinations with insight have been documented in the context of acquired deafness and have been compared with the visual pseudohallucinations of CBS.40, 57 B. Sensory deprivation experiments Hallucinations similar to those in CBS have been described by individuals subjected to sensory deprivation. The development of hallucinatory phenomena has been demonstrated under conditions such as ocular masking92, 158 and exposure to monotonous sensory environments.66 Heron et al66 subjected themselves to sensory (including visual) deprivation, and they noted that after a single day all investigators invariably experienced visual hallucinatory experiences, initially elementary, which later evolved in complexity and exhibited movement, both en bloc and internal. The typical progression of visual hallucinations from simple to complex, observed during experiments on perceptual isolation, has been interpreted to signify progression from lower to higher centers in the nervous system.159 Hallucinatory activity in patients undergoing bilateral ocular patching exhibits a strong relationship with duration of visual deprivation and manifests mainly during periods of reduced alertness, indicating that concurrence of sensory deprivation and reduced alertness is of causal significance in the development of hallucinatory experiences.158 C. Dreams and hallucinations The neurophysiological mechanisms underlying dreams and hallucinations may be similar, the former occurring during sleep and the latter during wakefulness.39 Dreams and hallucinations have been conceptualized as lying on a continuum, manifestation in the waking state being prevented by activity in ascending corticopetal nervous pathways. Disruption of such inhibitory mechanisms may “unmask” dreams—and the emergence of hallucinations.61 Reduced sensory input usually occurs during sleep; however, if specific sensory and non-specific ascending reticular input to sensory cortex drops below a threshold level even during the waking state, super-sensitivity to background activity in cerebral cortex may develop, with resultant hallucinatory experiences.94, 126 In this context it is interesting that fatigue and disturbances of vigilance have been implicated as relevant to the emergence of hallucinations,94, 109, 116, 145, 147 as they are more likely to occur during states of drowsiness. D. Theory of perceptual release The brain may actively exclude irrelevant sensory impulses from conscious perception, by means of an active censorship mechanism, in turn dependent upon normal sensory input. When afferent input is reduced below a threshold level (such as in disease of the eyes or visual pathway), the brain may then allow previously registered subconscious perceptions or engrams to emerge into consciousness, resulting in a hallucinatory experience.153, 154 E. The neuromatrix theory Contending that the occurrence of visual hallucinations is independent of the degree of visual impairment, some authors104 challenge the theory of perceptual release and refer to the neuromatrix theory,97, 98 which proposes the existence of a network of neurons, the neuromatrix, extending throughout the brain, capable of generating sensory phantoms. This neuromatrix is said to impart a pattern, the neurosignature, on all afferent inputs from the body, so that sensory experiences may have a quality of self and possess affective tone and cognitive meaning. These authors argue that changes to sensory input may trigger or modulate the output of this neuromatrix, but do not dictate the qualities of experience. F. Irritative and release hallucinations Cogan27 classified hallucinations into irritative and release variants and suggested that while the former are repetitive, stereotyped, and momentary, occurring secondary to electrical discharge at any point along the visual pathway, the latter are more likely to cause formed, continuous, variable complex visual hallucinations. He believed that complex visual hallucinations in patients with multi-factorial visual impairment represented release phenomena secondary to attenuation of visual sensory input due to pathology anywhere along the visual system, as a result of which they have much less localizing value than those of the irritative type. Many authors believe that CBS hallucinations represent release phenomena.27, 42, 82, 89, 94, 109, 111, 128, 132, 150 It has also been suggested that coexisting pathology of the central nervous system may have a further permissive effect on the release of hallucinatory activity.132 Ictal activity from a focal irritative center, possibly in the occipital or temporal cortices has also been implicated as causative in the genesis of visual hallucinations.16, 87, 122 G. Social isolation Social isolation has been implicated as etiological in the genesis of CBS hallucinations,70, 71, 77, 144, 148 supported by the observation of temporary cessation of hallucinatory experiences during hospitalization. Social isolation may predispose to a state of sensory deprivation, a well recognized predisposing factor for visual hallucinations.30 H. Senescence The possible role of senescence has been highlighted,27 in that it may bring about the disintegration of higher centers and facilitate the release of sub-cortical phenomena, resulting in hallucinations. Complex visual hallucinations may be more likely to manifest in the context of macular disease if superimposed on age related central nervous system changes.94 The requirement for disinhibition of higher cortical centers may therefore explain the almost exclusive incidence of CBS in the elderly.49 I. Psychological factors It has been suggested that the psychological desire to see under conditions of partial visual loss may produce visual hallucinations. However, the disappearance of hallucinatory experiences when vision is totally lost negates this possibility.150 Hallucinations have been postulated to involve the integrative activity of the mind152 and may be due to facilitation of a general capacity of the brain for imagery;20 indeed, CBS is reported to occur predominantly in individuals with high levels of education and in the creative professions.65, 121 J. anomalies of cerebral perfusion Abnormalities of perfusion of the cerebral cortex have been implicated in the etiology of complex visual hallucinations. Vertebro-basilar insufficiency with ischemia of the visual pathway;107, 117 asymmetrical hyperperfusion in the lateral temporal cortex, corpus striatum, and thalamus during hallucinatory experiences;2 reduced occipital perfusion;133 and mid-parietal and occipital hypoperfusion resembling a commonly described pattern in Alzheimer's disease58 have been demonstrated in studies with SPECT and magnetic resonance imaging.
Ix. Differential Diagnosis  The visually impaired are not immune to hallucinations secondary to other neuropsychiatric conditions or emotional disturbances;104 it is therefore important to exclude other possible causes of complex visual hallucinations, such as peduncular hallucinosis, Alzheimer's disease, delirium, Parkinsonism and levodopa-induced hallucinations, Lewy Body dementia, (recovery from) migraine coma, schizophrenia, medication, epilepsy, and hallucinations experienced during sleep–wake transitions.94, 136 Up to one-third of normal individuals at some point experience hypnagogic hallucinations,94 consisting of dramatic images in vivid colors, which, however, unlike those seen in CBS, invariably occur immediately before sleep, with the eyes closed and are frequently associated with auditory sensations.12 It has been suggested that the most common etiologies for visual hallucinations are dementia and delirium,134 especially in psychogeriatric patients.67 The possibility of delirium certainly merits careful consideration. However, in contrast with CBS, delirious subjects manifest impaired attention, disorganized thought processes, and abnormalities of sleep and orientation.150 A wide spectrum of pathology of the visual system has been described in Alzheimer's disease. It is suggested that visual hallucinations occurring in such patients may be related to visual dysfunction (compromised visual acuity and visual agnosia) frequently seen in this most common of dementias.22, 72, 73 Visual hallucinations in elderly subjects with Parkinson's disease may be similar to those in CBS. These patients often manifest impaired visual function, clear sensorium, and absence of hallucinations of other modalities. The pathogenesis may be a release phenomenon, similar to that of CBS.35 Visual hallucinations in Parkinson's disease are significantly associated with poor visual acuity, impaired cognition, depression, and severity of disease, but not with psychiatric disease, dose or duration of anti-Parkinsonian medication, or duration of illness.68 Brain stem lesions associated with hallucinations include peduncular hallucinosis, in which striking visual images, similar to those seen in CBS and the hypnagogic state, occur with preserved insight and consciousness.94 Visual hallucinations characteristic of CBS may occur in the early stages of Dementia with Lewy Body (DLB); it has therefore been suggested that patients with complex visual hallucinations be carefully followed up, in order to exclude DLB.142
X. Management  Physician awareness and compassion are the mainstays of management for CBS. Though there is no universally effective therapy, treatment may not always be necessary, especially in cognitively intact patients,149 since visual hallucinations often cease spontaneously, in response to either improvement or further deterioration of visual function.150 Moreover, many patients with CBS are not distressed by the content of their hallucinations, as much as by anxiety about the significance of their occurrence. A. History taking Because most patients do not mention their symptoms unless specifically asked, sensitive, sympathetic, specific, and comprehensive history taking is essential to ascertain the existence of complex visual hallucinations in elderly visually impaired patients.15, 19, 21, 42, 107, 139, 147 When questioned by sympathetic, understanding, and accepting interviewers, more visually impaired subjects may admit to hallucinatory experiences.104 B. Examination Once hallucinations have been documented, thorough ophthalmic and neurological examination,113, 149 including formal evaluation of the neuropsychological status,114 is recommended to determine any potentially treatable causal pathology. It is also important to exclude other causes of visual hallucinations, as discussed previously. Effective communication with psychiatrists and rehabilitation therapists involved in the care of the patient is valuable in this context. However, in the alert, well-oriented patient, a simple test of cognitive function such as the Mini Mental State Examination may be adequate, with further psychiatric evaluation perhaps indicated only in the context of cognitive impairment. C. Reassurance and counseling Patients with CBS may experience considerable anxiety, compounded by lack of awareness of the condition.104 Many patients express disappointment and amazement at unsympathetic reactions received from healthcare professionals when seeking advice regarding their hallucinations.60 Most patients experience relief when reassured that their condition is not a psychiatric disorder, but a recognized phenomenon with a name.147 Explanation and reassurance that the visions are benign and harmless, and do not signify mental illness therefore have a powerful therapeutic effect,15, 36, 104 so much so that it has been recommended that all blind individuals, even those who do not acknowledge the existence of hallucinations, should be informed of the possibility of their occurrence and advised that if they do occur, the hallucinations need not be a cause for distress.104 Cognitively intact patients may need no further measures, though patients in the early stages of dementia may prove more difficult to reassure, especially if lacking insight and experiencing visions of a distressing nature.149 It has been claimed that patients derive comfort from being told that their visual hallucinations will cease as their vision deteriorates further,122, 150 though it is difficult to understand how the knowledge of impending blindness can be of comfort. Reassurance and counseling are therefore the cornerstones of treatment. D. Maximizing visual function Optimizing visual function often has a beneficial effect on hallucinatory activity42, 82, 91, 116, 132 and may be the most effective treatment, though correction of the visual defect may not always be possible, especially in elderly patients.150 Optical means such prescription of spectacles or visual aids and surgical procedures such as cataract surgery may be employed for this purpose. E. Psychological therapy Techniques such as hypnosis, distraction, cognitive restructuring, and relaxation training, utilized in psychological therapy for phantom limb pain, have been advocated to minimize the unpleasant effects of persistent, intrusive, and troublesome visual hallucinations.104 F. Pharmacotherapy There is currently no universally effective pharmacotherapy for CBS. The evaluation of any potential remedy is further complicated by the fact that even without treatment, hallucinations sometimes fade away over a period of weeks to months. Moreover, because patients are often not distressed by their visions, and may even enjoy them, a therapeutic approach may not always be necessary. However, if hallucinations are frequent, non-resolving, distressing, or impairing quality of life, effective therapy is required.112 Drug therapy is rarely useful in CBS.83, 116 Anticonvulsants such as carbamazepine,17, 24, 25, 55, 77, 141 clonazepam,141 and valproate75 have been suggested as effective. A combination of carbamazepine and clonazepam has proved useful in some patients.141 It is suggested that the efficacy of carbamazepine may be due to inhibition of inter-hallucinatory persistent increased ventral extra-striate neuronal activity.24 Low-dose gabapentin (anti-convulsant) is reported to have produced permanent remission.112 On the basis that serotonergic pathways may be relevant to the pathogenesis of visual hallucinations, cisapride, a potent 5HT-3 antagonist, has also been used with reported success.106, 118 Anti-psychotic drugs (neuroleptics) have been used in treatment of CBS, but are generally only partially effective at eradicating hallucinatory activity.149 Varying degrees of success have been reported with thioridazine,62 haloperidol,26 and the atypical neuroleptics risperidone78 and melperone.13 Different neuroleptics may have varying effects on CBS (risperidone has been documented to worsen hallucinations and render them menacing); treatment should therefore be tailored to the individual patient.84 G. Social and environmental factors CBS is known to occur in the context of social isolation and sensory deprivation, improvement of which may have a beneficial effect.149 Symptoms may abate when alternative interests are pursued, such as television, music, and the company of friends. Environmental changes such as improved illumination may reduce hallucinatory activity,99, 149 perhaps by increasing the overall level of sensory stimulation. Treatment of depression, modification of the environment, and establishment of support groups, in which patients can share their experiences, may also be useful.
Xi. Discussion  There has been much controversy and disagreement about inclusion and exclusion criteria for CBS. Such criteria are arguably of limited relevance since they do not alter management in any way. In the pursuit of strict, well-defined criteria we perhaps overlook the clinical significance of this phenomenon—visual hallucinations can and do occur in patients with visual impairment. Such patients are often elderly and may be considerably distressed by their visions, the nature of which they do not understand. This is relevant and requires recognition and attention. CBS can be misdiagnosed and inappropriately treated. It is significant that the majority of information on CBS is contained in psychiatric rather than ophthalmic literature. This may indicate that patients who do admit to their hallucinatory experiences are judged mentally unstable and referred to psychiatrists, who then make the diagnosis of CBS. Visually impaired patients often present first in ophthalmic clinics, where CBS should ideally be diagnosed, or at least suspected. The majority of individuals with CBS suffer from impaired vision. Indeed both Lullin, the first described case, and later Bonnet himself, who lent his name to the syndrome, definitely manifested ocular pathology. In any case, ophthalmologists rarely encounter patients with formed visual hallucinations who do not have visual impairment. We therefore suggest that this eponym is reserved exclusively for patients experiencing visual hallucinations in the context of visual impairment secondary to pathology of the eyes or visual pathways. Charles Bonnet–type visual hallucinations in the absence of visual loss should be considered a separate entity. Hallucinatory symptoms are well recognized to abate upon both further decline and improvement of visual function. In this light, although cognitive dysfunction may be a contributory factor, it is unlikely to be of primary etiological significance. The most widely accepted explanation for the phenomenology of CBS is that of sensory deprivation—deafferentation—of the visual association areas of the cerebral cortex, with resultant release of hallucinatory activity. In both Alzheimer's disease and Parkinson's disease hallucinations occur more commonly in the context of visual impairment. In the light of suggestions that cognition may be impaired in CBS, it is tempting to speculate that the underlying pathology is similar, that both Alzheimer's and Parkinson's lie on a continuum with CBS, indeed that the occurrence of visual hallucinations in these contexts constitutes a form of CBS.
Xii. Conclusion  Eponymous labels are of limited value; however the term Charles Bonnet Syndrome may serve the essential function of reminding ophthalmologists that visual hallucinations can occur in the context of visual loss.29 Visual impairment is increasingly common in the elderly. Age-related macular degeneration, the leading cause of new irreversible blindness in the elderly,102 has been estimated to occur in 1 in 5 people over the age of 65 years.81 It is important that we recognize the occurrence of visual hallucinations in this large segment of our elderly population. The unfortunate patient with visual hallucinations, elderly, visually impaired, isolated, and afraid to seek help, has a genuine fear of impending insanity. The most powerful therapeutic approaches at our disposal remain empathy, sensitivity, communication, and reassurance.
Xiii. Method of Literature Search  We undertook a Medline search using the following keywords: Charles Bonnet, visual hallucinations, pseudohallucinations and phantom visions. Relevant citations from the reference lists of selected articles were also reviewed. Inclusion or exclusion of any article in the text was based on relevance and the necessity to avoid redundancy.
Outline  I. History II. Definitions III. Epidemiology A. Prevalence B. Age distribution C. Gender distribution D. Under-recognition IV. Clinical features A. Content B. Movement C. Stereotypy D. Triggering and relieving factors E. Course F. Hallucinations of other modalities G. Patients' reaction to their hallucinations H. Insight I. The mental state J. Fear of insanity K. Visual function L. Quality of life in visually impaired patients M. Neurological features N. Other risk factors V. Diagnostic criteria VI. Associated conditions VII. The Neuroanatomic basis of complex visual hallucinations VIII. Theories of pathogenesis A. Sensory deprivation—phantom vision B. Sensory deprivation experiments C. Dreams and hallucinations D. Theory of Perceptual Release E. The Neuromatrix theory F. Irritative and release hallucinations G. Social isolation H. Senescence I. Psychological factors J. Anomalies of cerebral perfusion IX. Differential diagnosis X. Management A. History taking B. Examination C. Reassurance and counseling D. Maximizing visual function E. Psychological therapy F. Pharmacotherapy G. Social and environmental factors XI. Discussion XII. Conclusion Acknowledgements  The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. The authors wish to thank Volker Schloenvoigt, Vladimir Thaller, Jack Kanski, Astrid Moreno-Chamorro, and Alison Alexander for kind help with translation of French, German, and Polish articles. They also wish to express their gratitude to the library staff at the Derriford Hospital, Plymouth: Jeremy Smith, Samantha Brown, Abbie Cooper, Sarah Cohen, Sue Morris, Marilyn Colquhoun, Jo Meddings, and Charlotte Steele, for their kind assistance above and beyond the call of duty in obtaining references, no matter how obscure. References  1.
1
Adachi N.
Charles Bonnet syndrome in leprosy; prevalence and clinical characteristics.
Acta Psychiatr Scand. 1996;93:279–281.
CrossRef
2.
2
Adachi N, Watanabe T, Matsuda H, Onuma T.
Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations (single photon emission computed tomography findings in patients with Charles Bonnet syndrome).
Psychiatry Clin Neurosci. 2000;54:157–162. MEDLINE |
CrossRef
3.
3
Adair DK, Keshavan MS.
The Charles Bonnet syndrome and grief reaction.
Am J Psychiatry. 1988;145:895–896. 4.
4
Alroe CJ, McIntyre JN.
Visual hallucinations. The Charles Bonnet syndrome and bereavement.
Med J Aust. 1983;2:674–675. 5.
5
American Psychiatry Association Committee on Nomenclature and Statistics: Diagnostic and statistical manual of mental disorders. Washington DC, American Psychiatry Association, 1994, ed 4, p 767 6.
6
Anderson SW, Rizzo M.
Hallucinations following occipital lobe damage (the pathological activation of visual representations).
J Clin Exp Neuropsychol. 1994;16:651–663. MEDLINE |
CrossRef
7.
7
Arya DK.
Charles Bonnet syndrome.
Br J Psychiatry. 1995;167:114–115. MEDLINE 8.
8
Asaad G, Shapiro B.
Hallucinations (theoretical and clinical overview).
Am J Psychiatry. 1986;143:1088–1097. 9.
9
Au Eong KG, Fujii GY, Ng EW, et al.
Transient formed visual hallucinations following macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Am J Ophthalmol. 2001;131:664–666. Abstract | Full Text |
Full-Text PDF (588 KB)
|
CrossRef
10.
10
Ball C.
Charles Bonnet syndrome.
Br J Psychiatry. 1995;166:677–678. MEDLINE |
CrossRef
11.
11
Barodawala S, Mulley GP.
Visual hallucinations.
J R Coll Physicians Lond. 1997;31:42–48. MEDLINE 12.
12
Bartlett JEA.
A case of organised visual hallucinations in an old man with cataract, and their relationship to the phenomena of the phantom limb.
Brain. 1951;74:363–373. MEDLINE 13.
13
Batra A, Bartels M, Wormstall H.
Therapeutic options in Charles Bonnet syndrome.
Acta Psychiatr Scand. 1997;96:129–133.
CrossRef
14.
14
Bentall RP.
The illusion of reality (a review and integration of psychological research on hallucinations).
Psychol Bull. 1990;107:82–95. MEDLINE |
CrossRef
15.
15
Berrios GE, Brook P.
Visual hallucinations and sensory delusions in the elderly.
Br J Psychiatry. 1984;144:662–664. MEDLINE |
CrossRef
16.
16
Berrios GE, Brook P.
The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly.
Age Ageing. 1982;11:17–23. MEDLINE 17.
17
Bhatia MS, Khastgir U, Malik SC.
Charles Bonnet syndrome.
Br J Psychiatry. 1992;161:409–410. MEDLINE |
CrossRef
18.
18
Bonnet C: Essai analytique sur les facultes de l'ame. Copenhagen and Geneva, Philibert, 1769, ed 2, pp 176–8 19.
19
Borruat FX: [Visual hallucinations and illusions, symptoms frequently misdiagnosed by the practitioner]. Klin Monatsbl Augenheilkd 214:324–7, 1999 20.
20
Brasic JR.
Hallucinations.
Percept Mot Skills. 1998;86:851–877. MEDLINE 21.
21
Brown GC, Murphy RP.
Visual symptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome.
Arch Ophthalmol. 1992;110:1251–1256. MEDLINE 22.
22
Chapman FM, Dickinson J, McKeith I, Ballard C.
Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimers disease (treatment implications).
Am J Psychiatry. 1999;156:1983–1985. 23.
23
Chatterjee A, Southwood MH.
Cortical blindness and visual imagery.
Neurology. 1995;45:2189–2195. MEDLINE 24.
24
Chaudhuri A.
Charles Bonnet syndrome (an example of cortical dissociation syndrome affecting vision).
J Neurol Neurosurg Psychiatry. 2000;69:704–705. MEDLINE |
CrossRef
25.
25
Chen CS, Lin SF, Chong MY.
Charles Bonnet syndrome and multiple sclerosis.
Am J Psychiatry. 2001;158:1158–1159.
CrossRef
26.
26
Chen J, Gomez M, Veit S, O'Dowd MA.
Visual hallucinations in a blind elderly woman (Charles Bonnet syndrome, an underrecognized clinical condition).
Gen Hosp Psychiatry. 1996;18:453–455.
Full-Text PDF (326 KB)
|
CrossRef
27.
27
Cogan DG.
Visual hallucinations as release phenomena.
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973;188:139–150. 28.
28
Cohn R.
Phantom vision.
Arch Neurol. 1971;25:468–471. MEDLINE 29.
29
Cole M.
Charles Bonnet Syndrome an example of cortical dissociation syndrome affecting vision?.
J Neurol Neurosurg Psychiatry. 2001;71:134. MEDLINE |
CrossRef
30.
30
Cole MG.
Charles Bonnet hallucinations (a case series).
Can J Psychiatry. 1992;37:267–270. MEDLINE 31.
31
Damas-Mora J, Skelton-Robinson M, Jenner FA.
The Charles Bonnet syndrome in perspective.
Psychol Med. 1982;12:251–261. MEDLINE |
CrossRef
32.
32
de Morsier G.
Le Syndrome de Charles Bonnet (hallucinations visuelles des viellards sans deficience mentale).
Ann Med Psychol. 1967;125:677–702. 33.
33
de Morsier G.
Les Hallucinations.
Rev Otoneuroophtalmol. 1938;16:244–352. MEDLINE 34.
34
de Morsier G.
Les automatismes visuels. Hallucinations rétrochiasmatiques.
Schweiz Med Wochenschr. 1936;66:700–708. 35.
35
Diederich NJ, Pieri V, Goetz CG: [Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison]. Fortschr Neurol Psychiatr 68:129–36, 2000 36.
36
Dlugon U: [Charles Bonnet syndrome]. Psychiatr Pol 34:307–16, 2000 37.
37
Dodd J, Heffeman A, Blake J.
Visual hallucinations associated with Charles Bonnet Syndrome—an ever increasing diagnosis.
Ir Med J. 1999;92:344–345. MEDLINE 38.
38
Duke-Elder S, Scott GI.
Disorders of perception (visual hallucinations).
In:
Duke-Elder S editors. System of Ophthalmology, Vol. XII. London: Henry Kimpton; 1971;p. 562–569. 39.
39
Evarts EV.
A neurophysiologic theory of hallucinations.
In:
West LJ editors. Hallucinations. New York: Grune and Stratton; 1962;p. 1–14. 40.
40
Fenelon G, Marie S, Ferroir JP, Guillard A.
Hallucinose musicale (7 cas).
Rev Neurol (Paris). 1993;149:462–467. MEDLINE 41.
41
Fernandes LH, Scassellati-Sforzolini B, Spaide RF.
Estrogen and visual hallucinations in a patient with Charles Bonnet syndrome.
Am J Ophthalmol. 2000;129:407. Abstract | Full Text |
Full-Text PDF (146 KB)
|
CrossRef
42.
42
Fernandez A, Lichtshein G, Vieweg WV.
The Charles Bonnet syndrome (a review).
J Nerv Ment Dis. 1997;185:195–200. MEDLINE |
CrossRef
43.
43
Ffytche DH, Howard RJ, Brammer MJ, et al.
The anatomy of conscious vision (an fMRI study of visual hallucinations).
Nat Neurosci. 1998;1:738–742. MEDLINE |
CrossRef
44.
44
Fitzgerald RG.
Visual phenomenology in recently blind adults.
Am J Psychiatry. 1971;127:1533–1539. 45.
45
Fitzgerald RG, Ebert JN, Chambers M.
Reactions to blindness (a four-year follow-up study).
Percept Mot Skills. 1987;64:363–378. MEDLINE 46.
46
Fluornoy T.
Le case de Charles Bonnet.
Arch Psychol Suisse Romande. 1902;1:1–23. 47.
47
Foerster O.
The cerebral cortex in man.
Lancet. 1931;2:309–312.
CrossRef
48.
48
Fong SY, Wing YK.
Charles Bonnet syndrome with major depression in a Chinese middle-aged man.
Aust NZ J Psychiatry. 1997;31:769–771. 49.
49
Fuchs T, Lauter H.
Charles Bonnet Syndrome and musical hallucinations in the elderly.
In:
Katona C, Levy R editor. Delusions and hallucinations in old age. Royal College of Psychiatrists: Gaskell; 1992;p. 187–198. 50.
50
Galynker I, Kampf R, Rosenthal R.
Dose related visual hallucinations in macular degeneration patients receiving phenelzine.
Am J Psychiatry. 1994;151:450. 51.
51
Gelder M, Gath D, Mayou R: Oxford Textbook of Psychiatry. Oxford. Oxford University Press 1991, ed 2, pp 5–8 52.
52
Girkin CA, Miller NR.
Central disorders of vision in humans.
Surv Ophthalmol. 2001;45:379–405. Abstract | Full Text |
Full-Text PDF (2900 KB)
|
CrossRef
53.
53
Gold K, Rabins PV.
Isolated visual hallucinations and the Charles Bonnet syndrome (a review of the literature and presentation of six cases).
Compr Psychiatry. 1989;30:90–98.
CrossRef
54.
54
Goldberg KB, Goldberg RE.
Is seeing believing? Visual hallucinations in age-related macular degeneration and Charles Bonnet.
J Ophthalmic Nurs Technol. 2000;19:39–42. MEDLINE 55.
55
Gorgens K, Liedtke M: [Charles Bonnet syndrome]. Psychiatr Prax 25:85–6, 1998 56.
56
Gray M, Jones IR.
Type II diabetes mellitus presenting as the Charles Bonnet syndrome.
J R Soc Med. 1997;90:503. MEDLINE 57.
57
Griffiths TD.
Musical hallucinosis in acquired deafness. Phenomenology and brain substrate.
Brain. 2000;123:2065–2076.
CrossRef
58.
58
Guerra-Garcia H.
Charles Bonnet syndrome and early dementia.
J Am Geriatr Soc. 1997;45:893–894. MEDLINE 59.
59
Hart CT.
Formed visual hallucinations (a symptom of cranial arteritis).
Br Med J. 1967;3:643–644. MEDLINE 60.
60
Hart J.
Phantom visions (real enough to touch).
Elder Care. 1997;9:30–32. MEDLINE 61.
61
Hartmann E.
Dreams and other hallucinations (an approach to the underlying mechanism).
In:
Siegal RK, West LJ editor. Hallucinations (Behaviour, Experience and Theory). New York: John Wiley and Sons; 1975;p. 71–79. 62.
62
Hartmann PM, Kosko DA, Cohn JA.
The Charles Bonnet syndrome (pseudohallucinations) in an AIDS patient with cytomegalovirus retinitis.
J Nerv Ment Dis. 1995;183:549–550. MEDLINE |
CrossRef
63.
63
Hauge T.
Catheter vertebral angiography.
Acta Radiol. 1954;109(Suppl):1–219. 64.
64
Hécaen H, Albert ML.
Disorders of visual perception.
In:
Hécaen H, Albert ML editor. Human Neuropsychology. New York: John Wiley & Sons; 1978;p. 144–167. 65.
65
Hécaen H, Badarocco JG.
Les hallucinations visuelles au cours des ophthalmopathies et des lesions des nerfds et du chiasma optiques.
Evol Psychiatr (Paris). 1956;21:157–179. 66.
66
Heron W, Doane BK, Scott TH.
Visual disturbances after prolonged perceptual isolation.
Can J Psychol. 1956;10:13–18. MEDLINE |
CrossRef
67.
67
Holroyd S.
Visual hallucinations in a geriatric psychiatry clinic (prevalence and associated diagnoses).
J Geriatr Psychiatry Neurol. 1996;9:171–175. MEDLINE 68.
68
Holroyd S, Currie L, Wooten GF.
Prospective study of hallucinations and delusions in Parkinsons disease.
J Neurol Neurosurg Psychiatry. 2001;70:734–738. MEDLINE |
CrossRef
69.
69
Holroyd S, Rabins PV.
A three-year follow-up study of visual hallucinations in patients with macular degeneration.
J Nerv Ment Dis. 1996;184:188–189. MEDLINE 70.
70
Holroyd S, Rabins PV, Finkelstein D, et al.
Visual hallucinations in patients with macular degeneration.
Am J Psychiatry. 1992;149:1701–1706. 71.
71
Holroyd S, Rabins PV, Finkelstein D, Lavrisha M.
Visual hallucinations in patients from an ophthalmology clinic and medical clinic population.
J Nerv Ment Dis. 1994;182:273–276. MEDLINE |
CrossRef
72.
72
Holroyd S, Sheldon-Keller A.
A study of visual hallucinations in Alzheimers disease.
Am J Geriatr Psych. 1995;3:198–205. 73.
73
Holroyd S, Shepherd ML.
Alzheimers disease (a review for the ophthalmologist).
Surv Ophthalmol. 2001;45:516–524. Abstract | Full Text |
Full-Text PDF (77 KB)
|
CrossRef
74.
74
Hori H, Terao T, Nakamura J.
Charles Bonnet syndrome with auditory hallucinations (a diagnostic dilemma).
Psychopathology. 2001;34:164–166. MEDLINE |
CrossRef
75.
75
Hori H, Terao T, Shiraishi Y, Nakamura J.
Treatment of Charles Bonnet syndrome with valproate.
Int Clin Psychopharmacol. 2000;15:117–119. MEDLINE |
CrossRef
76.
76
Horowitz MJ.
The imagery of visual hallucinations.
J Nerv Ment Dis. 1964;138:513–523. MEDLINE 77.
77
Hosty G.
Charles Bonnet syndrome (a description of two cases).
Acta Psychiatr Scand. 1990;82:316–317.
CrossRef
78.
78
Howard R, Meehan O, Powell R, Mellers J.
Successful treatment of Charles Bonnet Syndrome type visual hallucinosis with low-dose Risperidone.
Int J Geriatr Psychiatry. 1994;9:677–678. 79.
79
Howard R, Williams S, Bullmore E.
Cortical response to exogenous visual stimulation during visual hallucinations.
Lancet. 1995;345:70.
CrossRef
80.
80
Johnson FC, Smith LD.
Cognition.
In:
Thompson T, Mathias P editor. Lyttle's mental health and disorder. London: Bailliere Tindall; 1994;p. 175–240. 81.
81
Kahn HA, Leibowitz HM, Ganley JP, et al.
The Framingham Eye Study. I. Outline and major prevalence findings.
Am J Epidemiol. 1977;106:17–32. MEDLINE 82.
82
Kolmel HW.
Complex visual hallucinations in the hemianopic field.
J Neurol Neurosurg Psychiatry. 1985;48:29–38. MEDLINE |
CrossRef
83.
83
Kolmel HW.
Visual illusions and hallucinations.
In:
Kennard C editors. Baillieres Clinical Neurology, Vol.2, No. 2. London: Bailliere Tindall; 1993;p. 243–264. 84.
84
Kornreich C, Dan B, Verbanck P, Pelc I.
Treating Charles Bonnet syndrome (understanding inconsistency).
J Clin Psychopharmacol. 2000;20:396. MEDLINE |
CrossRef
85.
85
Kurata A, Miyasaka Y, Yoshida T, et al.
Venous ischemia caused by dural arteriovenous malformation. Case report.
J Neurosurg. 1994;80:552–555. MEDLINE |
CrossRef
86.
86
Lalla D, Primeau F.
Complex visual hallucinations in macular degeneration.
Can J Psychiatry. 1993;38:584–586. MEDLINE 87.
87
Lance JW.
Simple formed hallucinations confined to the area of a specific visual field defect.
Brain. 1976;99:719–734. MEDLINE 88.
88
Lauber HL, Lewin B.
A clinical and psychological study of optic hallucinations in the elimination of vision.
Arch Psychiatr Nervenkr. 1958;197:15–31. MEDLINE |
CrossRef
89.
89
Lepore FE.
Spontaneous visual phenomena with visual loss (104 patients with lesions of retinal and neural afferent pathways).
Neurology. 1990;40:444–447. MEDLINE 90.
90
Levêque de Pouilly JS: Eloge de Charles Bonnet, Lausanne, Henbach, 1794, pp 120–121 91.
91
Levine AM.
Visual hallucinations and cataracts.
Ophthalmic Surg. 1980;11:95–98. 92.
92
Linn L, Kahn RL, Coles R.
Patterns of behaviour disturbance following cataract extraction.
Am J Psychiatry. 1953;110:281–289. 93.
93
Loewenstein JI.
Visual hallucinations in patients with choroidal neovascularization.
JAMA. 1994;272:243. MEDLINE 94.
94
Manford M, Andermann F.
Complex visual hallucinations. Clinical and neurobiological insights.
Brain. 1998;121:1819–1840.
CrossRef
95.
95
Maricle RA, Turner LD, Lehman KD.
The Charles Bonnet syndrome (a brief review and case report).
Psychiatr Serv. 1995;46:289–291. MEDLINE 96.
96
McNamara ME, Heros RC, Boller F.
Visual hallucinations in blindness (the Charles Bonnet syndrome).
Int J Neurosci. 1982;17:13–15. MEDLINE |
CrossRef
97.
97
Melzack R.
Phantom limbs and the concept of a neuromatrix.
Trends Neurosci. 1990;13:88–92. MEDLINE |
CrossRef
98.
98
Melzack R.
Phantom limbs, the self and the brain. (the D.O.
Hebb Memorial Lecture). Can Psychol. 1989;30:1–16. 99.
99
Mojica TR, Bailey PP.
Hallucinations in the vision-impaired elderly (the Charles Bonnet syndrome).
Nurse Pract. 2000;25:74–76. MEDLINE |
CrossRef
100.
100
Murphy RP, Storer D, Bressler NM, Orr P.
Visual hallucinations in patients with age related macular degeneration.
Invest Ophthalmol Vis Sci. 1990;31(Suppl):48;
. 101.
101
Nadarajah J.
Visual hallucinations and macular degeneration (an example of the Charles Bonnet syndrome).
Aust NZ J Ophthalmol. 1998;26:63–65. 102.
102
National Advisory Eye Council: Vision Research, a National Plan, 1994–1998. Bethesda, MD: US Dept of Health and Human Services, NIH publication, 1993, pp 93–3186 103.
103
Naville E.
Hallucinations visuelles a letat normal.
Arch Psychologie. 1908;8:1–8. 104.
104
Needham W, Taylor RE.
Benign visual hallucinations, or phantom vision in visually impaired and blind persons.
J Vis Impair Blind. 1992;86:245–248. 105.
105
Needham WE, Taylor RE.
Atypical Charles Bonnet hallucinations (an elf in the woodshed, a spirit of evil, and the cowboy malefactors).
J Nerv Ment Dis. 2000;188:108–115. MEDLINE |
CrossRef
106.
106
Nevins M.
Charles Bonnet syndrome.
J Am Geriatr Soc. 1997;45:894–895. MEDLINE 107.
107
Norton-Willson L, Munir M.
Visual perceptual disorders resembling the Charles Bonnet syndrome.
A study of. 1987;434(consecutive patients referred to a psychogeriatric unit. Fam Pract 4):27–35. 108.
108
O'Reilly R, Chamberlaine C.
Charles Bonnet syndrome (incidence and demographic and clinical features).
Can J Psychiatry. 1996;41:259–260. MEDLINE 109.
109
Olbrich HM, Engelmeier MP, Pauleikhoff D, Waubke T.
Visual hallucinations in ophthalmology.
Graefes Arch Clin Exp Ophthalmol. 1987;225:217–220.
CrossRef
110.
110
Ormond AW: Visual hallucinations in sane people. BMJ 367–7, 1925 111.
111
Özsancak C, Auzou P.
Palinopsie au cours d'un syndrome de Charles Bonnet.
Presse Med. 1998;27:359. MEDLINE 112.
112
Paulig M, Mentrup H.
Charles Bonnets syndrome (complete remission of complex visual hallucinations treated by gabapentin).
J Neurol Neurosurg Psychiatry. 2001;70:813–814. MEDLINE |
CrossRef
113.
113
Pfeiffer RF, Bodis-Wollner I.
Charles Bonnet syndrome.
J Am Geriatr Soc. 1996;44:1128–1129. MEDLINE 114.
114
Pliskin NH, Kiolbasa TA, Towle VL, et al.
Charles Bonnet syndrome (an early marker for dementia?).
J Am Geriatr Soc. 1996;44:1055–1061. MEDLINE 115.
115
Pliskin NH, Towle VL, Kiolbasa TA: In reply to Teunisse RJ: The Charles Bonnet Syndrome, insight and cognitive impairment. J Am Geriatr Soc 45; 892, 1997 116.
116
Podoll K, Osterheider M, Noth J: [The Charles Bonnet syndrome]. Fortschr Neurol Psychiatr 57:43–60, 1989 117.
117
Price J, Whitlock FA, Hall RT.
The psychiatry of vertebro-basilar insufficiency with the report of a case.
Psychiatr Clin (Basel). 1983;16:26–44. 118.
118
Ranen NG, Pasternak RE, Rovner BW.
Cisapride in the treatment of visual hallucinations caused by vision loss (the Charles Bonnet syndrome).
Am J Geriatr Psychiatry. 1999;7:264–266. MEDLINE |
CrossRef
119.
119
Rao V.
Charles Bonnet syndrome, time to drop the name?.
Int J Geriatr Psychiatry. 1997;12:413. MEDLINE |
CrossRef
120.
120
Raudino F.
Visual evoked potentials (VEP) in the Charles Bonnet Syndrome (Report of a case).
Acta Neurol (Napoli). 1987;9:53–55. MEDLINE 121.
121
Reyes-Ortiz CA, Camacho ME, Mulligan T.
Charles Bonnet syndrome in a centenarian.
JAMA. 1996;276:451–452. MEDLINE 122.
122
Rosenbaum F, Harati Y, Rolak L, Freedman M.
Visual hallucinations in sane people (Charles Bonnet syndrome).
J Am Geriatr Soc. 1987;35:66–68. MEDLINE 123.
123
Rousseaux M, Debrock D, Cabaret M, Steinling M.
Visual hallucinations with written words in a case of left parietotemporal lesion.
J Neurol Neurosurg Psychiatry. 1994;57:1268–1271. MEDLINE |
CrossRef
124.
124
Safran AB, Kline LB, Glaser JS.
Positive visual phenomena in optic nerve and chiasm disease (photopsias and photophobia).
In:
Glaser JS editors. Neuro-ophthalmology, Vol. 10. St Louis: CV Mosby; 1980;p. 225–231. 125.
125
Santhouse AM, Howard RJ, Ffytche DH.
Visual hallucinatory syndromes and the anatomy of the visual brain.
Brain. 2000;123:2055–2064.
CrossRef
126.
126
Scheibel ME, Scheibel AB.
Hallucinations and brain stem reticular core.
In:
West LJ editors. Hallucinations. New York: Grune and Stratton; 1962;p. 15–35. 127.
127
Schultz G, Melzack R.
Visual hallucinations and mental state.
A study of. 1993;14(Charles Bonnet syndrome hallucinators. J Nerv Ment Dis 181):639–643. 128.
128
Schultz G, Melzack R.
The Charles Bonnet syndrome (phantom visual images).
Perception. 1991;20:809–825. MEDLINE 129.
129
Schultz G, Needham W, Taylor R, et al.
Properties of complex hallucinations associated with deficits in vision.
Perception. 1996;25:715–726. MEDLINE 130.
130
Schwartz TL, Vahgei L.
Charles Bonnet syndrome in children.
J AAPOS. 1998;2:310–313. Abstract |
Full-Text PDF (450 KB)
|
CrossRef
131.
131
Sedman G.
A comparative study of pseudohallucinations, imagery, and true hallucinations.
Br J Psychiatry. 1966;112:9–17. MEDLINE |
CrossRef
132.
132
Siatkowski RM, Zimmer B, Rosenberg PR.
The Charles Bonnet syndrome. Visual perceptive dysfunction in sensory deprivation.
J Clin Neuroophthalmol. 1990;10:215–218. 133.
133
Sichart U, Fuchs T: [Visual hallucinations in elderly patients with reduced vision: Charles Bonnet syndrome]. Klin Monatsbl Augenheilkd 200:224–7, 1992 134.
134
Sims A, Mundt C, Berner P, Barocka A.
Descriptive phenomenology.
In:
Gelder MG, Lopez-Ibor JJ, Andreasen NC editor. New Oxford Textbook of Psychiatry. Oxford: Oxford Medical Publications; 2000;p. 55–70. 135.
135
Symonds C, MacKenzie I.
Bilateral loss of vision from cerebral infarction.
Brain. 1957;80:415–455. MEDLINE 136.
136
Takata K, Inoue Y, Hazama H, Fukuma E.
Night-time hypnopompic visual hallucinations related to REM sleep disorder.
Psychiatry Clin Neurosci. 1998;52:207–209. MEDLINE |
CrossRef
137.
137
Taylor FK.
On pseudo-hallucinations.
Psychol Med. 1981;11:265–271. MEDLINE |
CrossRef
138.
138
Taylor J, Holmes G, Walshe FMR.
Evolution and dissolution of the nervous system.
In:
Taylor J, Holmes G, Walshe FMR editor. Selected writings of John Hughlings Jackson, Vol. 2. London: Hodder and Stoughton; 1932;p. 3–120. 139.
139
Taylor RE, Mancil GL, Kramer SH.
Visual hallucinations (meaning and management).
J Am Optom Assoc. 1986;57:889–892. MEDLINE 140.
140
Terao T.
Hallucinations in Alzheimers disease and Charles Bonnet syndrome.
Am J Psychiatry. 2000;157:2062.
CrossRef
141.
141
Terao T.
Effect of carbamazepine and clonazepam combination on Charles Bonnet syndrome (a case report).
Hum Psychopharmacol Clin Exp. 1998;13:451–453. 142.
142
Terao T, Collinson S.
Charles Bonnet Syndrome and dementia.
Lancet. 2000;355:2168. Full Text |
Full-Text PDF (54 KB)
|
CrossRef
143.
143
Teunisse RJ.
Charles Bonnet syndrome, insight and cognitive impairment.
J Am Geriatr Soc. 1997;45:892–893. MEDLINE 144.
144
Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al.
Social and psychological characteristics of elderly visually handicapped patients with the Charles Bonnet Syndrome.
Compr Psychiatry. 1999;40:315–319. |
CrossRef
145.
145
Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al.
Risk indicators for the Charles Bonnet syndrome.
J Nerv Ment Dis. 1998;186:190–192. MEDLINE |
CrossRef
146.
146
Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG.
The Charles Bonnet syndrome (a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen).
Br J Psychiatry. 1995;166:254–257. MEDLINE |
CrossRef
147.
147
Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al.
Visual hallucinations in psychologically normal people (Charles Bonnets syndrome).
Lancet. 1996;347:794–797. Abstract |
CrossRef
148.
148
Teunisse RJ, Zitman FG, Raes DC.
Clinical evaluation of 14 patients with the Charles Bonnet syndrome (isolated visual hallucinations).
Compr Psychiatry. 1994;35:70–75.
CrossRef
149.
149
Thorpe L.
Treatment of psychiatric disorders in Late life.
Can J Psychiatry. 1997;42(Suppl 1):19S–27S. 150.
150
Tueth MJ, Cheong JA, Samander J.
The Charles Bonnet syndrome (a type of organic visual hallucinosis).
J Geriatr Psychiatry Neurol. 1995;8:1–3. MEDLINE 151.
151
Vaphiades MS, Celesia GG, Brigell MG.
Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways.
Neurology. 1996;47:408–417. MEDLINE 152.
152
Weinberger LM, Grant FC.
Visual hallucinations and their neuro-optical correlates.
Arch Ophthalmol. 1940;23:166–199. 153.
153
West LJ.
A general theory of hallucinations and dreams.
In:
West LJ editors. Hallucinations. New York: Grune and Stratton; 1962;p. 275–291. 154.
154
West LJ.
A clinical and theoretical overview of hallucinatory phenomena.
In:
Siegal RK, West LJ editor. Hallucinations (Behaviour, Experience and Theory). New York: John Wiley and Sons; 1975;p. 287–311. 155.
155
White CP, Jan JE.
Visual hallucinations after acute visual loss in a young child.
Dev Med Child Neurol. 1992;34:259–261. MEDLINE 156.
156
White NJ.
Complex visual hallucinations in partial blindness due to eye disease.
Br J Psychiatry. 1980;136:284–286. MEDLINE |
CrossRef
157.
157
Williams RA, Brody BL, Thomas RG, et al.
The psychosocial impact of macular degeneration.
Arch Ophthalmol. 1998;116:514–520. MEDLINE 158.
158
Ziskind E, Jones H, Filante W, Goldberg J.
Observations on mental symptoms in eye patched patients (hypnagogic symptoms in sensory deprivation).
Am J Psychiatry. 1960;116:893–900. 159.
159
Zuckerman M, Cohen N.
Sources of reports of visual and auditory sensations in perceptual isolation experiments.
Psychol Bull. 1964;62:1–20. MEDLINE |
CrossRef
1 Royal Eye Infirmary, Plymouth, United Kingdom 2 Department of Psychiatry, Mount Gould Hospital, Plymouth, United Kingdom 3 Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, United Kingdom Reprint address: G.J. Menon, Specialist Registrar, Royal Eye Infirmary, Apsley Road, Plymouth, PL4 6 PL, United Kingdom
PII: S0039-6257(02)00414-9 © 2003 Elsevier Science Inc. All rights reserved. | |
|